Umbralisib tosylate

CAS No.	1532533-72-4	Cat. No.	BCP24684
Name	Umbralisib tosylate
Synonyms	TGR-1202 tosylate; RP5264 tosylate;TGR-1202 (4-methylbenzenesulfonate);
Formula	C38H32F3N5O6S	M. Wt	743.75

Description	Umbralisib Tosylate is the tosylate form of umbralisib, an orally bioavailable, selective inhibitor of the delta isoform of the 110 kDa catalytic subunit of class I phosphoinositide-3 kinases (PI3K) with potential antineoplastic activity. umbralisib inhibits PI3K and prevents the activation of the PI3K/AKT kinase signaling pathway. This decreases proliferation and induces cell death in susceptible tumor cells. Unlike other isoforms of PI3K, PI3K-delta is expressed primarily in tumor cells and cells of the hematopoietic lineage. The targeted inhibition of PI3K-delta allows for PI3K signaling in normal, non-neoplastic cells. PI3K, an enzyme often overexpressed in cancer cells, plays a crucial role in tumor cell regulation and survival.
Pathways	PI3K/Akt/mTOR
Targets	PI3K

Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.

For product details of different batches, please contact our Customer

Products are for research use only and not for human use. We do not sell to patients.